troglitazone has been researched along with ly 171883 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Fukumoto, S; Hosoi, M; Koyama, H; Morii, H; Nishizawa, Y; Tanaka, S; Yamakawa, K | 1 |
2 other study(ies) available for troglitazone and ly 171883
Article | Year |
---|---|
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Peroxisome proliferator-activated receptor-gamma agonists increase vascular endothelial growth factor expression in human vascular smooth muscle cells.
Topics: Acetophenones; Cells, Cultured; Chromans; Endothelial Growth Factors; Gene Expression Regulation; Humans; Lymphokines; Muscle, Smooth, Vascular; Peroxisome Proliferators; Pioglitazone; Receptors, Cytoplasmic and Nuclear; RNA, Messenger; Tetrazoles; Thiazoles; Thiazolidinediones; Time Factors; Transcription Factors; Troglitazone; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors; Vasodilator Agents | 2000 |